NEW YORK--(BUSINESS WIRE)--Jun 4, 2012-- OneMedPlace announced today

that its 3rd Annual 'OneMedForum NY' will include sessions on how

dramatic changes in regulation, through the passing of the JOBS Act,

will create opportunities for investors and entrepreneurs. The

conference will also feature expert panels in the most promising areas

of healthcare and life science investment followed by company


"With the passage of the JOBS Act over 70 years of securities

regulation has changed. When coupled with health reform and advances

in digital technology changing how healthcare is delivered, we are at

a period of historic risk and opportunity for investors and

entrepreneurs," said Brett Johnson, President of OneMedPlace. "Our

objective is to provide unique insight and to connect promising

innovative companies with investors seeking outsized returns."

In addition to expert panels and workshops, the conference will

include presentations by almost 50 companies that are developing

technologies in the most promising areas of health and medicine,

including regenerative medicine, diagnostics, oncology, and consumer

health information. Investor guides that include a near comprehensive

list of companies and resources in these areas will also be provided

to delegates.

"We are inviting companies that represent investment opportunity and

whose innovations we think will impact the marketplace," said Brett

Johnson."These are companies that you would not likely see at typical

investment banking conferences."

A dedicated track on the JOBS Act will look at how changes to the

general solicitation rules (Regulation D) can change the capital

raising process. It will consider crowdfunding and how biotech and

medical device companies can use it as part of an overall strategy to

not only raise capital, but also galvanize global audiences of

individuals passionate about various areas of medicine.

Held one week after the rules on crowdfunding and general solicitation

are to be issued by the SEC, the event will include analysis by

leading experts and regulators on how the legislation will affect

capital raising. The conference will open with a reception on July

11th and a keynote address by David Weild IV, former NASDAQ ViceChair.

Mr. Weild's research played a fundamental role in the passage of the

JOBS Act, and his ongoing consultation with the SEC is expected to

shape the rules, particularly as related to IPOs.

OneMedResearch, which focuses on small public companies that are

significantly undervalued, will be sponsoring a public company track.

Public company presentations will also be streamed live on OneMedTV

beginning 9 am on July 12th.

'OneMedForum NY 2012' is targeted toward venture capital, family fund,

private equity, angel and corporate strategic investors. Sponsors

include Ronald Trahan Associates Inc. ('RTA'), Grant Thornton, Greater

Zurich Area AG, MPR Associates, AdvaMed2012, Torreya Partners,

Association for Corporate Growth New York (ACG), EdgeTech Law LLP,

Aptiv Solutions, International Venture Club, New York Venture Capital

Association, New York Biotechnology Association, Reed Smith, Medmarc,

BDO, and Lincoln Park Capital.

About OneMedPlace

OneMedPlace is a research and media organization building a virtual

community that connects emerging companies seeking capital,

distribution, and visibility with investors and strategic partners

looking for health and medical innovations to invest in, acquire,

license, distribute, purchase or utilize.

About OneMedForum

Established in 2008, OneMedForumis the conference component of

OneMedPlace, which provides an integrated media platform to showcase

the best ideas and innovations in health and medicine globally. The

media platform also includes: OneMedRadio; OneMedTV, OneMedSentinel; a

global database of companies; and OneMedResearch, which tracks

promising lesser-known microcap public companies.

CONTACT: OneMedPlace

Herina Ayot, +212-734-1008



SOURCE: OneMedPlace

Copyright Business Wire 2012

PUB: 06/04/2012 11:56 AM/DISC: 06/04/2012 11:56 AM